|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號(hào)：G797495 |
| 產(chǎn)品名稱：GSK2636771 |
| 產(chǎn)品CAS：1372540-25-4 |
| 規(guī)格含量：5mg |
| 產(chǎn)品價(jià)格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號(hào): |
G797495 |
| 名稱: |
GSK2636771 |
| 別名: |
2-Methyl-1-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-6-(4-morpholinyl)-1H-benzimidazole-4-carboxylic Acid; |
| CAS號(hào): |
1372540-25-4 |
| 分子式: |
C??H??F?N?O? |
| 外觀: |
淡黃色固體 |
| 熔點(diǎn): |
>225°C (dec.) |
| 分子量: |
433.42 |
| 儲(chǔ)存: |
-20°C Freezer |
| 溶解度: |
DMSO (Slightly), Methanol (Slightly) |
| 種類: |
Research Tools; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應(yīng)用: |
GSK2636771 is a potent, orally bioavailable, PI3Kβ-selective inhibitor, sensitive to PTEN null cell lines. |
| 參考文獻(xiàn) |
|
|
|
|
?您的位置：
